ARTRYA Ltd
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography sca… Read more
ARTRYA Ltd (AYA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.467x
Based on the latest financial reports, ARTRYA Ltd (AYA) has a cash flow conversion efficiency ratio of -0.467x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.94 Million) by net assets (AU$21.29 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ARTRYA Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how ARTRYA Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ARTRYA Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ARTRYA Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AudioCodes Ltd
NASDAQ:AUDC
|
0.028x |
|
Lanzhou Zhuangyuan Pasture Co Ltd
SHE:002910
|
0.056x |
|
Ahlatci Dogal Gaz Dagitim Enerji ve Yatirim A.S.
IS:AHGAZ
|
0.093x |
|
Morris State Bancshares Inc
OTCQX:MBLU
|
N/A |
|
VIVO Cannabis Inc
PINK:ABCCF
|
-0.028x |
|
Albatron Technology Co Ltd
TWO:5386
|
0.357x |
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
|
0.045x |
|
Weihai Baihe Biology Technological Co. Ltd.
SHG:603102
|
N/A |
Annual Cash Flow Conversion Efficiency for ARTRYA Ltd (2019–2025)
The table below shows the annual cash flow conversion efficiency of ARTRYA Ltd from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$21.29 Million | AU$-14.27 Million | -0.670x | +26.89% |
| 2024-06-30 | AU$16.80 Million | AU$-15.41 Million | -0.917x | -160.90% |
| 2023-06-30 | AU$30.56 Million | AU$-10.74 Million | -0.351x | -48.68% |
| 2022-06-30 | AU$40.64 Million | AU$-9.61 Million | -0.236x | -711.62% |
| 2021-06-30 | AU$51.05 Million | AU$-1.49 Million | -0.029x | +95.53% |
| 2020-06-30 | AU$2.49 Million | AU$-1.62 Million | -0.651x | -478.82% |
| 2019-06-30 | AU$852.97K | AU$-95.94K | -0.112x | -- |